Last reviewed · How we verify
NCT04122573: PEACP
Prospective Multicenter Study for Early Evaluation of Acute Chest Pain
trial testing Coronary angiography in Chest Pain in 10,000 participants. Status unknown.
31 October 2021
Quick facts
| Lead sponsor | West China Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 10,000 |
| Start date | 1 November 2019 |
| Primary completion | 31 October 2021 |
| Estimated completion | 31 October 2022 |
| Sites | 9 locations across China |
Drugs / interventions tested
- Coronary angiography
- CT angiography of aorta
- CT angiography of pulmonary arteries.
- Electrocardiogram
- Cardiac Troponin
Conditions studied
- Chest Pain — all drugs for Chest Pain →
- Acute Aortic Dissection — all drugs for Acute Aortic Dissection →
- Pulmonary Embolism — all drugs for Pulmonary Embolism →
- Acute Myocardial Infarction Type 1 — all drugs for Acute Myocardial Infarction Type 1 →
Sponsor
West China Hospital
Who can join
Adults 18 to 90, any sex, with Chest Pain or Acute Aortic Dissection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study, clinical database and blood sample bank of acute chest pain (ACP) will be established at chest pain center of multi-center hospital. To explore new biomarkers and screen clinical indicators with effective risk stratification and prognostic evaluation for ACP through proteomics technology and statistics methods. Risk stratification and short-term and long-term prognostic evaluation models for high-risk ACP will be established using large data analysis.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Long- and very long-chain ceramides are predictors of acute kidney injury in patients with acute coronary syndrome: the PEACP study.
Liang L, Li D, Zeng R, Zhang H, et al · · 2023 · cited 11× · PMID 37081501 · DOI 10.1186/s12933-023-01831-6 -
Prognostic value of interleukin-33, sST2, myeloperoxidase, and matrix metalloproteinase-9 in acute aortic dissection.
Jia Y, Li D, Yu J, Jiang W, et al · · 2022 · cited 7× · PMID 36684579 · DOI 10.3389/fcvm.2022.1084321 -
Association Between Plasma Ceramides and One-Year Mortality in Patients with Acute Coronary Syndrome: Insight from the PEACP Study.
Li F, Li D, Yu J, Jia Y, et al · · 2023 · cited 5× · PMID 37050937 · DOI 10.2147/cia.s402253
Verify or expand the search:
- PubMed search for NCT04122573
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Coronary angiography
Trials testing the same drug.
- NCT06966531 — Prevalence of Myocarditis in Patients Suspected Myocardial Infarction With Non-Obstructive Coronary Arteries · not yet recruiting
- NCT06368635 — The Cerebral Microcirculation Diseases and Coronary Microcirculation Disease Study · recruiting
- NCT06182683 — Concurrent OCT and FFR-guided PCI in CAD · NA · recruiting
- NCT05725616 — Effectiveness of the Anatomical Snuff Box Approach for Coronary Angiography · NA · completed
- NCT05184426 — MuLtimodality EvaluatiOn of aNtibody mEdiated Damage in Heart Transplantation (LEONE-HT) · active not recruiting
Other recruiting trials for Chest Pain
Currently open trials in the same condition.
- NCT06853626 — One-hoUr Troponin Using a High-sensitivity Point-Of-Care Assay in Emergency Primary Care · NA · recruiting
- NCT07247669 — Evaluation and Optimization of Telephone Triage Using Artificial Intelligence (AI) Models for the Detection of Demands f · active not recruiting
- NCT06239974 — Vericiguat in Patients With Coronary Microvascular Dysfunction Causing Stable Chest Pain (V-COM) · NA · recruiting
- NCT06520150 — Evaluation of the Effectiveness of Two Methods of Regional Anesthesia During S-ICD Implantation Procedure. · NA · recruiting
- NCT07435168 — CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis · NA · recruiting
Other West China Hospital trials
Trials by the same sponsor.
- NCT07583654 — Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors · Phase 1 · not yet recruiting
- NCT07583914 — Safety, Tolerability, and Preliminary Antitumor Activity of Non-Cationic Peptide-CD47 siRNA in Advanced Solid Tumors · Phase 1 · not yet recruiting
- NCT07492914 — Neoadjuvant Sacituzumab Govitecan Plus Tagitanlimab for Resectable Head and Neck Squamous Cell Carcinoma · Phase 2 · recruiting
- NCT07507097 — Study on the Optimal Head Position for Patients With Severe Acute Ischemic Stroke · NA · not yet recruiting
- NCT07472933 — Vebotolimab Combined With Ptorlimab for EGFR-positive Refractory Advanced Biliary Tract Malignancies · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04122573 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by West China Hospital
- Last refreshed: 29 November 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04122573.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing